Key result
Rheumatoid arthritis was associated with a higher unadjusted 8-year incidence of cIMT ≥75th percentile, but this lost significance after adjusting for confounders (OR 2.43; 95% CI 0.94-6.27; p=0.06).
Why the study?
Does Rheumatoid Arthritis increase the incidence of subclinical atherosclerosis (measured by cIMT) in middle-aged adults without prior cardiovascular conditions?
Cohort (n=1,138)
Yes
Does Rheumatoid Arthritis increase the incidence of subclinical atherosclerosis (measured by cIMT) in middle-aged adults without prior cardiovascular conditions?
Odds Ratio: 2.43 (95% CI 0.94–6.27)
p-value: p=0.06
Rheumatoid arthritis is associated with an increased unadjusted risk of incident subclinical atherosclerosis over 8 years, but this association is attenuated and non-significant after adjusting for traditional cardiovascular risk factors.
Background Rheumatoid Arthritis (RA) is a chronic autoimmune disease characterised by systemic inflammation and a possible increased risk of subclinical atherosclerosis. Carotid intima-media thickness (cIMT) is an early marker of atherosclerotic disease and can be performed noninvasively using ultrasound imaging. cIMT is a well-established marker of subclinical atherosclerosis and an independent predictor of cardiovascular events. Purpose The aim of this study was to evaluate the cross-sectional and prospective associations of cIMT, including its 8-year incidence, in individuals with and without RA, free of prior cardiovascular conditions at baseline, using data from a large multicentre cohort study. Methods A case-cohort study was conducted with 161 participants with RA and 977 controls without RA, selected from a randomly assigned subcohort at baseline from a prospective cohort study of adults aged 35–74 years. This analysis included baseline (2008–2010) and 8-year follow-up data (2016–2018). RA diagnosis was based on physician confirmation, use of disease-modifying antirheumatic drugs, or positive serological biomarkers. cIMT was measured by ultrasonography at baseline and follow-up. Associations between RA and cIMT prevalence and incidence were assessed using linear and logistic regression models, adjusted for sociodemographic and cardiovascular risk factors. P-value < 0.05 was considered statistically significant. Results The mean ± SD age of participants was 51.0 ± 8.4 years, with 58.3% being women. Participants with RA were significantly older (53.1 ± 8.7 vs 50.6 ± 8.3 years) and more likely to be female (79.5% vs 54.8%). The incidence of cIMT ≥75th percentile over the 8-year follow-up was significantly higher in the RA group. In the unadjusted model, RA was associated with a significantly higher Odds Ratio (OR) of cIMT ≥75th percentile (OR: 2.58, 95% Confidence Interval (95% CI): 1.01–6.60, p = 0.04), although this association lost significance after adjusting for sociodemographic and cardiovascular risk factors (OR: 2.43, 95% CI: 0.94–6.27, p = 0.06; OR: 2.46, 95% CI: 0.95–6.38, p = 0.06). No significant associations were found in linear or logistic regression analyses for the association of RA with cIMT prevalence (Table 1). Conclusion RA was associated with a higher incidence of cIMT ≥75th percentile over the 8-year follow-up, suggesting increased subclinical atherosclerosis. However, this association lost significance after adjusting for confounders, and no significant association was found for the prevalence of cIMT.
No takes yet. Share an insight, caveat, or question.
Estrada et al. (2025) conducted a cohort in Rheumatoid Arthritis (n=1,138). Rheumatoid arthritis vs. Without rheumatoid arthritis was evaluated on Incidence of cIMT ≥75th percentile (OR 2.43, 95% CI 0.94-6.27, p=0.06). Rheumatoid arthritis was associated with a higher unadjusted 8-year incidence of cIMT ≥75th percentile, but this lost significance after adjusting for confounders (OR 2.43; 95% CI 0.94-6.27; p=0.06).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: